Surgery Partners, Inc.
SGRY
$22.80
$0.301.33%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 83.87% | -204.03% | -10,750.00% | -546.94% | -182.01% |
Total Depreciation and Amortization | 15.80% | 7.72% | 9.00% | 73.70% | 42.62% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -29.18% | 12.61% | 121.49% | 27.38% | 113.57% |
Change in Net Operating Assets | 22.33% | -50.93% | 52.05% | -229.36% | 30.65% |
Cash from Operations | -1.81% | -85.26% | 77.96% | -37.67% | 58.93% |
Capital Expenditure | 13.01% | -8.10% | -12.63% | -6.88% | -4.26% |
Sale of Property, Plant, and Equipment | -- | 220.00% | -- | 100.00% | -100.00% |
Cash Acquisitions | 98.10% | 19.41% | -180.77% | -401.89% | -7,400.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -19.44% | -61.11% | 59.15% | -154.55% | 88.14% |
Cash from Investing | 100.86% | 8.06% | -92.25% | -93.75% | -242.84% |
Total Debt Issued | -84.71% | 10.96% | -62.40% | 81.27% | 10,304.72% |
Total Debt Repaid | 78.90% | 0.75% | 75.64% | -78.57% | -5,371.79% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 14.41% | -57.88% | 8.49% | -7.96% | -35.68% |
Cash from Financing | -133.02% | -4.73% | 207.62% | 64.22% | 486.94% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -26.50% | -275.70% | 218.95% | -85.84% | 141.56% |